Fig. 1 · Structure
Documents & Downloads
Repaglinide-d5
Insulin Secretagogue
Repaglinide-d5 is a deuterium-labeled form of Repaglinide, an insulin secretagogue that stimulates insulin secretion from pancreatic beta cells. This compound is primarily utilized in the research of type 2 diabetes mellitus to better understand mechanisms of insulin regulation and glucose homeostasis. Its unique labeling facilitates pharmacokinetic studies and metabolic tracing in various biological assays.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 1217709-85-7 |
| Applications | Insulin Secretagogue |
| Formula | C27H31D5N2O4 |
| Molecular Weight | 457.62 |
| Synonyms | AG-EE 623ZW d5 |
| SMILES | O=C(O)C1=CC=C(CC(N[C@H](C2=CC=CC=C2N3CCCCC3)CC(C)C)=O)C=C1OC([2H])([2H])C([2H])([2H])[2H] |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.